Global Tissue Diagnostics Market Size study, By Product (Consumables, Instruments), By Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow, Special Staining), By Disease (Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Cancer, Other Cancers), By End-User (Hospitals, Research Laboratories, Others), and Regional Forecasts 2022-2028
- BIZ4983367
- 200 Pages
- July 2022
- Medical Devices
The key regions considered for the global Tissue Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the easy accessibility to advanced technologies and surging demand for cancer diagnosis supplements. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rapidly growing aging population, as well as the rising prevalence of chronic lifestyle & genetic diseases, would create lucrative growth prospects for the Tissue Diagnostics Market across the Asia-Pacific region.
Major market players included in this report are:
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Thermo Fisher Scientific, Inc
Abbott
Agilent Technologies Inc.
Merck KGAA
Sakura Finetek Japan Co., Ltd
Abcam Plc.
Becton, Dickinson and Company
Cell Signaling Technology, Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product Products of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Consumables
Instruments
By Technology:
Immunohistochemistry
In Situ Hybridization
Digital Pathology and Workflow
Special Staining
By Disease:
Breast Cancer
Non-small Cell Lung Cancer
Prostate Cancer
Gastric Cancer
Other Cancers
By End-User:
Hospitals
Research Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Tissue Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Tissue Diagnostics Market, by Region, 2020-2028 (USD Million)
1.2.2. Tissue Diagnostics Market, by Product, 2020-2028 (USD Million)
1.2.3. Tissue Diagnostics Market, by Technology, 2020-2028 (USD Million)
1.2.4. Tissue Diagnostics Market, by Disease, 2020-2028 (USD Million)
1.2.5. Tissue Diagnostics Market, by End-User, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Tissue Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Tissue Diagnostics Market Dynamics
3.1. Tissue Diagnostics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of cancer
3.1.1.2. Increasing advancements in imaging techniques and increasing affordability of diagnostics
3.1.2. Market Challenges
3.1.2.1. High costs associated with R&D and clinical trials
3.1.2.2. Strict regulatory requirements
3.1.3. Market Opportunities
3.1.3.1. Rising number of clinical trials pertaining to cancer drugs
3.1.3.2. Increasing private diagnostics centers
Chapter 4. Global Tissue Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Tissue Diagnostics Market, by Product
6.1. Market Snapshot
6.2. Global Tissue Diagnostics Market by Product, Performance – Potential Analysis
6.3. Global Tissue Diagnostics Market Estimates & Forecasts by Product, 2018-2028 (USD Million)
6.4. Tissue Diagnostics Market, Sub Segment Analysis
6.4.1. Consumables
6.4.2. Instruments
Chapter 7. Global Tissue Diagnostics Market, by Technology
7.1. Market Snapshot
7.2. Global Tissue Diagnostics Market by Technology, Performance - Potential Analysis
7.3. Global Tissue Diagnostics Market Estimates & Forecasts by Technology, 2018-2028 (USD Million)
7.4. Tissue Diagnostics Market, Sub Segment Analysis
7.4.1. Immunohistochemistry
7.4.2. In Situ Hybridization
7.4.3. Digital Pathology and Workflow
7.4.4. Special Staining
Chapter 8. Global Tissue Diagnostics Market, by Disease
8.1. Market Snapshot
8.2. Global Tissue Diagnostics Market by Disease, Performance - Potential Analysis
8.3. Global Tissue Diagnostics Market Estimates & Forecasts by Disease, 2018-2028 (USD Million)
8.4. Tissue Diagnostics Market, Sub Segment Analysis
8.4.1. Breast Cancer
8.4.2. Non-small Cell Lung Cancer
8.4.3. Prostate Cancer
8.4.4. Gastric Cancer
8.4.5. Other Cancers
Chapter 9. Global Tissue Diagnostics Market, by End-User
9.1. Market Snapshot
9.2. Global Tissue Diagnostics Market by End-User, Performance - Potential Analysis
9.3. Global Tissue Diagnostics Market Estimates & Forecasts by End-User, 2018-2028 (USD Million)
9.4. Tissue Diagnostics Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Research Laboratories
9.4.3. Others
Chapter 10. Global Tissue Diagnostics Market, Regional Analysis
10.1. Tissue Diagnostics Market, Regional Market Snapshot
10.2. North America Tissue Diagnostics Market
10.2.1. U.S. Tissue Diagnostics Market
10.2.1.1. Product breakdown estimates & forecasts, 2018-2028
10.2.1.2. Technology breakdown estimates & forecasts, 2018-2028
10.2.1.3. Disease breakdown estimates & forecasts, 2018-2028
10.2.1.4. End-User breakdown estimates & forecasts, 2018-2028
10.2.2. Canada Tissue Diagnostics Market
10.3. Europe Tissue Diagnostics Market Snapshot
10.3.1. U.K. Tissue Diagnostics Market
10.3.2. Germany Tissue Diagnostics Market
10.3.3. France Tissue Diagnostics Market
10.3.4. Spain Tissue Diagnostics Market
10.3.5. Italy Tissue Diagnostics Market
10.3.6. Rest of Europe Tissue Diagnostics Market
10.4. Asia-Pacific Tissue Diagnostics Market Snapshot
10.4.1. China Tissue Diagnostics Market
10.4.2. India Tissue Diagnostics Market
10.4.3. Japan Tissue Diagnostics Market
10.4.4. Australia Tissue Diagnostics Market
10.4.5. South Korea Tissue Diagnostics Market
10.4.6. Rest of Asia Pacific Tissue Diagnostics Market
10.5. Latin America Tissue Diagnostics Market Snapshot
10.5.1. Brazil Tissue Diagnostics Market
10.5.2. Mexico Tissue Diagnostics Market
10.6. Rest of The World Tissue Diagnostics Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. F. Hoffmann-La Roche Ltd.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Danaher Corporation
11.2.3. Thermo Fisher Scientific, Inc
11.2.4. Abbott
11.2.5. Agilent Technologies Inc.
11.2.6. Merck KGAA
11.2.7. Sakura Finetek Japan Co., Ltd
11.2.8. Abcam Plc.
11.2.9. Becton, Dickinson and Company
11.2.10. Cell Signaling Technology, Inc
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
TABLE 1. Global Tissue Diagnostics Market, report scope
TABLE 2. Global Tissue Diagnostics Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Tissue Diagnostics Market estimates & forecasts by Product 2018-2028 (USD Million)
TABLE 4. Global Tissue Diagnostics Market estimates & forecasts by Technology 2018-2028 (USD Million)
TABLE 5. Global Tissue Diagnostics Market estimates & forecasts by Disease 2018-2028 (USD Million)
TABLE 6. Global Tissue Diagnostics Market estimates & forecasts by End-User 2018-2028 (USD Million)
TABLE 7. Global Tissue Diagnostics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Tissue Diagnostics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Tissue Diagnostics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Tissue Diagnostics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Tissue Diagnostics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Tissue Diagnostics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Tissue Diagnostics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Tissue Diagnostics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Tissue Diagnostics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. Global Tissue Diagnostics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 18. U.S. Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. U.S. Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 20. Canada Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 21. Canada Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. Canada Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 23. UK Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 24. UK Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. UK Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 26. Germany Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 27. Germany Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. Germany Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 29. RoE Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 30. RoE Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. RoE Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 32. China Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 33. China Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. China Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 35. India Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 36. India Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. India Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 38. Japan Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 39. Japan Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. Japan Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 41. RoAPAC Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 42. RoAPAC Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. RoAPAC Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 44. Brazil Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 45. Brazil Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Brazil Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 47. Mexico Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 48. Mexico Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. Mexico Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 50. RoLA Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 51. RoLA Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. RoLA Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 53. Row Tissue Diagnostics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 54. Row Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. Row Tissue Diagnostics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 56. List of secondary sources, used in the study of global Tissue Diagnostics Market
TABLE 57. List of primary sources, used in the study of global Tissue Diagnostics Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
